Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating the metabolic syndrome.

Cristina Bianchi1, Giuseppe Penno, Fabiola Romero

  • 1University of Pisa, Department of Endocrinology and Metabolism, Cisanello University Hospital, Pisa, Italy. c.bianchi@ao-pisa.toscana.it

Expert Review of Cardiovascular Therapy
|May 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal and neonatal outcomes in migrant women with gestational diabetes. A retrospective cohort study in Italy.

Acta diabetologica·2026
Same author

SodiuM glucose cotrANsporter-2 (SGLT-2) inhibitors in the treatment of type II DiAbetes in Tuscany: utiLizatiOn patteRns, and relatEd clinical use evaluation; the MANDALORE study protocol.

Frontiers in endocrinology·2026
Same author

Fetal-restricted hematopoietic progenitors arise from hemogenic endothelium in vitelline and umbilical arteries.

Nature cardiovascular research·2026
Same author

Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes?

Diabetes, obesity & metabolism·2026
Same author

Superiority of 1 h plasma glucose vs fasting plasma glucose, 2 h plasma glucose and HbA<sub>1c</sub> for the diagnosis of type 2 diabetes.

Diabetologia·2025
Same author

Gestational Diabetes in Migrants: Prevalence and Metabolic Profile During Pregnancy: A Retrospective Italian Cohort Study.

Diabetes/metabolism research and reviews·2025

Metabolic syndrome (MS) management involves lifestyle changes and medications to reduce risks of cardiovascular disease and Type 2 diabetes mellitus (T2DM). Aggressive intervention combining diet, exercise, and pharmacotherapy is key for effective treatment.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Disorders

Background:

  • Metabolic syndrome (MS) is a growing health concern characterized by insulin resistance.
  • MS significantly elevates the risk of cardiovascular disease and Type 2 diabetes mellitus (T2DM).

Purpose of the Study:

  • To outline current evidence-based strategies for managing metabolic syndrome.
  • To highlight the importance of integrated lifestyle and pharmacologic interventions.

Main Methods:

  • Review of current evidence supporting aggressive intervention for MS.
  • Discussion of lifestyle modifications (diet, exercise) and pharmacologic agents for MS components.

Main Results:

  • Lifestyle modifications effectively reduce key MS indicators like waistline, BMI, blood pressure, and lipid profiles.

Related Experiment Videos

  • Pharmacologic interventions include insulin sensitizers (metformin, thiazolidinediones), lipid-lowering drugs (statins, fibrates), and antihypertensives (ACE inhibitors, ARBs).

    • Conclusions:

    • Integrated management combining lifestyle changes and pharmacotherapy is crucial for controlling MS.
    • Future research may identify novel therapeutic targets for more effective MS treatments.